Detailed annotation info for ACL00003644;
| Annotation Name | Putative fatty acid elongation protein 3 related cluster | |||||||||
| Score | 206&emsp | |||||||||
| E-value | 8e-16 | |||||||||
| % Sequence Identity | 41% (51/123) | |||||||||
| Locus | ||||||||||
| EC Number | ||||||||||
| COG Function | ||||||||||
| KEGG Pathway | ||||||||||
| Source | Accession | Description | Score | E-value | % Sequence Identity | Locus | EC Number | Informative Hit | Function/Pathway | GeneOntology |
| SSU | No hits found | 0 | ||||||||
| LSU | No hits found | 0 | ||||||||
| uniref90 | UniRef90_P49191 | Putative fatty acid elongation protein 3 related cluster | 206 | 8e-16 | 41% (51/123) | 1 | GO:0016021|integral to membrane|IEA | |||
| nr | P49191 | Putative fatty acid elongation protein 3 gb|AAA82288.2| Fatty acid elongation protein 3 [Caenorhabditis elegans] | 206 | 2e-15 | 41% (51/123) | 1 | ||||
| cog | No hits found | 0 | ||||||||
| kegg | cel:D2024.3 | Fatty acid elongation protein 3 | 206 | 7e-16 | 41% (51/123) | 1 | ||||
| smart | No hits found | 0 | ||||||||
| pfam | PF01151 | pfam01151, ELO, GNS1/SUR4 family | 247 | 8e-22 | 31% (42/134) | ELO | 1 | |||
| pfam2 | PF05792 | pfam05792, Candida_ALS, Candida agglutinin-like protein (ALS) | 124 | 1e-07 | 22% (41/183) | Candida_ALS | 2 | |||
| pfam3 | PF05109 | pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | 130 | 3e-08 | 23% (44/187) | Herpes_BLLF1 | 3 | |||
| pfam4 | PF05955 | pfam05955, Herpes_gp2, Equine herpesvirus glycoprotein gp2 | 124 | 1e-07 | 26% (41/155) | Herpes_gp2 | 4 | |||
| pfam5 | PF05471 | pfam05471, Podocalyxin, Podocalyxin | 127 | 7e-08 | 21% (35/165) | Podocalyxin | 5 | |||
| pfam6 | PF02956 | pfam02956, TT_ORF1, TT viral orf 1 | 119 | 6e-07 | 40% (25/62) | TT_ORF1 | 6 | |||
| pfam7 | PF04929 | pfam04929, Herpes_DNAp_acc, Herpes DNA replication accessory factor | 109 | 8e-06 | 18% (20/108) | Herpes_DNAp_acc | 7 | |||
| est_others | BX754440 | BX754440 XGC-gastrula Xenopus tropicalis cDNA clone TGas103d08 3'. | 74 | 7e-13 | 61% (11/18) | 1 | ||||